Alkermes News Today

AdvisorShares Investments LLC reduced its stake in Alkermes plc (NASDAQ:ALKS – Free Report) by 25.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,746 shares of the company’s stock after selling 3,715 shares during the period. AdvisorShares Investments LLC’s holdings in […]

Sectoral Asset Management Inc. reduced its position in Alkermes plc (NASDAQ:ALKS – Free Report) by 93.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,330 shares of the company’s stock after selling 228,930 shares during the period. Sectoral Asset […]

Rhenman & Partners Asset Management AB cut its stake in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 8.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 340,000 shares of the company’s stock after selling 30,000 shares during the quarter. […]

Rhenman & Partners Asset Management AB cut its stake in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 8.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 340,000 shares of the company’s stock after selling 30,000 shares during the quarter. […]

Eagle Asset Management Inc. lowered its holdings in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 31.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 595,597 shares of the company’s stock after selling 272,276 shares during the period. Eagle Asset Management Inc. owned about […]

Alkermes will present new data for its investigational narcolepsy treatment, ALKS 2680, at SLEEP 2024 in Houston.

Alkermes plc (NASDAQ:ALKS – Free Report) – Zacks Research boosted their Q3 2024 earnings per share estimates for Alkermes in a report released on Wednesday, May 22nd. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.63 for the quarter, up from their previous estimate of $0.57. The […]

Artisan Partners Limited Partnership grew its position in Alkermes plc (NASDAQ:ALKS – Free Report) by 10.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,066,020 shares of the company’s stock after buying an additional 188,289 shares during the period. Artisan Partners Limited Partnership owned 1.24% […]

BioPharma

DUBLIN, May 29, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in fireside chat presentations at two upcoming investor conferences. Jefferies